Skip to content

13F-HR filed by DIADEMA PARTNERS LP

DIADEMA PARTNERS LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 15:31:07 UTC, with 148 holding rows worth $780,451,639.

Accession
0001892688-26-000170
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 148 entries on the cover page, a total value of $780,451,639 stated on the cover page (in dollars after the unit check, H1), rows summing to $780,451,639 with VALUE read as dollars as filed, 13F file number 028-25172. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VIKING THERAPEUTICS INC92686J106COM1,361,900$44,397,940dollars as filedput
Bristol-Myers Squibb Company110122108COM600,000$37,440,000dollars as filedcall
VIKING THERAPEUTICS INC92686J106COM1,139,400$37,144,440dollars as filedcall
VIKING THERAPEUTICS INC92686JAA4NOTE 2.000%10/11,000,000$32,600,000dollars as filedprincipal
KODIAK SCIENCES INC50015M109COM297,000$28,155,600dollars as filedput
UNITED THERAPEUTICS CORP DEL COM91307C102Stock47,500$25,739,775dollars as filedcall
UNITED THERAPEUTICS CORP DEL COM91307C102Stock46,222$25,047,240dollars as filed
BIONTECH SE SPONSORED ADS09075V102ADR250,000$24,575,000dollars as filedcall
KODIAK SCIENCES INC50015M109COM251,700$23,861,160dollars as filedcall
Bristol-Myers Squibb Company110122108COM330,600$20,629,440dollars as filedput
COGENT BIOSCIENCES INC19240Q201COM641,947$20,555,143dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share518,100$18,483,218dollars as filedcall
KYMERA THERAPEUTICS INC501575104COM160,900$17,987,011dollars as filedcall
ABIVAX SA-00370M103SPONSORED ADS178,444$17,746,445dollars as filed
BRIDGEBIO PHARMA INC10806XAJ1NOTE 1.750% 3/0250,000$16,450,000dollars as filedprincipal
SUMMIT THERAPEUTICS INC86627T108COM960,200$16,236,982dollars as filedcall
BIOMARIN PHARMACEUTICAL INC09061G101COM255,383$15,322,980dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock70,004$14,369,021dollars as filed
NOVARTIS AG SPONSORED ADR66987V109ADR100,000$14,257,000dollars as filedput
VIKING THERAPEUTICS INC92686J106COM433,166$14,121,212dollars as filed
GRAIL INC384747101COM100,000$14,012,000dollars as filedcall
ABIVAX SA-00370M103SPONSORED ADS137,700$13,635,054dollars as filedput
SUMMIT THERAPEUTICS INC86627T108COM801,400$13,551,674dollars as filedput
INCYTE CORP COM45337C102Stock105,400$12,790,290dollars as filedput
CORCEPT THERAPEUTICS INC218352102COM100,000$11,523,000dollars as filedcall
ABIVAX SA-00370M103SPONSORED ADS114,600$11,347,692dollars as filedcall
VAXCYTE INC COM92243G108Stock197,800$11,254,820dollars as filedput
VAXCYTE INC COM92243G108Stock153,100$8,711,390dollars as filedcall
MODERNA INC60770K107COM44,400$8,550,108dollars as filedcall
SPDR SER TR78464A870S&P BIOTECH50,000$7,884,000dollars as filedput
LIQUIDIA CORPORATION COM NEW53635D202Stock257,200$7,782,872dollars as filedcall
BRIDGEBIO PHARMA INC10806X102COM103,960$6,840,568dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR221,764$6,717,232dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock421,107$6,026,041dollars as filed
UNIQURE NVN90064101SHS235,400$5,687,264dollars as filedcall
CORBUS PHARMACEUTICALS21833P301COM NEW800,000$5,456,000dollars as filedcall
VIRIDIAN THERAPEUTICS INC92790C104COM257,076$5,293,195dollars as filed
UNIQURE NVN90064101SHS199,300$4,815,088dollars as filedput
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK497,300$4,709,431dollars as filedcall
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK484,400$4,587,268dollars as filedput
LIQUIDIA CORPORATION COM NEW53635D202Stock150,000$4,539,000dollars as filedput
Johnson & Johnson478160104COM17,000$4,500,580dollars as filed
BIOHAVEN LTDG1110E107COM317,000$4,231,950dollars as filedcall
INDIVIOR PHARMACEUTICALS INC45579U109COM117,512$4,212,805dollars as filed
VAXCYTE INC COM92243G108Stock72,850$4,145,165dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK305,000$4,038,200dollars as filed
ARCUS BIOSCIENCES INC03969F109COM153,810$3,972,912dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK200,000$3,816,000dollars as filedcall
KODIAK SCIENCES INC50015M109COM38,991$3,696,347dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock120,000$3,631,200dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock60,000$3,517,200dollars as filed
ABSCI CORPORATION00091E109COM304,200$3,276,234dollars as filedcall
ARCUS BIOSCIENCES INC03969F109COM124,100$3,205,503dollars as filedcall
COGENT BIOSCIENCES INC19240Q201COM100,000$3,202,000dollars as filedcall
PHARVARIS NVN69605108COMMON STOCK100,000$3,172,000dollars as filedput
SELLAS LIFE SCIENCES GROUP I81642T209COM NEW250,000$3,077,500dollars as filedput
IMMUNOCORE HLDGS PLC ADS45258D105ADR100,000$3,029,000dollars as filedcall
IOVANCE BIOTHERAPEUTICS INC462260100COM200,000$2,964,000dollars as filedcall
RHYTHM PHARMACEUTICALS INC76243J105COM30,000$2,856,450dollars as filed
PHARVARIS NVN69605108COMMON STOCK90,000$2,854,800dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK181,947$2,789,248dollars as filed
SELLAS LIFE SCIENCES GROUP I81642T209COM NEW200,000$2,462,000dollars as filedcall
INTELLIA THERAPEUTICS INC45826J105COM200,000$2,412,000dollars as filedcall
CORVUS PHARMACEUTICALS INC221015100COM204,811$2,359,423dollars as filed
MANNKIND CORP COM NEW56400P706Stock604,025$2,355,698dollars as filed
INSMED INC COM PAR $.01457669307Stock18,497$2,111,248dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock250,000$2,082,500dollars as filed
INVENTIVA SA46124U107ADS553,126$2,064,403dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK422,619$2,058,155dollars as filed
ADMA BIOLOGICS INC000899104COM200,000$2,006,000dollars as filedcall
SPRUCE BIOSCIENCES INC85209E208COM NEW40,435$1,964,332dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM44,346$1,800,448dollars as filed
PROTHENA CORP PLC SHSG72800108Stock208,167$1,744,439dollars as filed
PELTHOS THERAPEUTICS INC171126204COM SHS80,760$1,696,768dollars as filed
VERASTEM INC92337C203COMMON STOCK200,000$1,610,000dollars as filedcall
CELCUITY INC15102K100COM20,000$1,590,400dollars as filedcall
AMYLYX PHARMACEUTICALS INC03237H101COM53,152$1,546,723dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM133,400$1,536,768dollars as filedcall
ALUMIS INC022307102COM200,000$1,478,000dollars as filedcall
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS398,869$1,467,838dollars as filed
ABCELLERA BIOLOGICS INC COM00288U106Stock100,000$1,459,000dollars as filedcall
PROQR THERAPEUTICS NVN71542109SHS EURO826,286$1,371,635dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK361,367$1,362,354dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM50,000$1,321,500dollars as filedcall
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK179,950$1,313,635dollars as filed
JADE BIOSCIENCES INC008064206COM NEW91,259$1,282,189dollars as filed
MINERALYS THERAPEUTICS INC603170101COM50,000$1,256,500dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK38,008$1,227,278dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock100,000$1,170,000dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock13,169$1,096,846dollars as filed
EDITAS MEDICINE INC28106W103COM400,000$1,028,000dollars as filedcall
MACROGENICS INC556099109COM262,059$1,011,548dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock70,000$939,400dollars as filedcall
UNICYCIVE THERAPEUTICS INC90466Y202COMMON STOCK192,600$904,257dollars as filedcall
JASPER THERAPEUTICS INC471871202COM NEW35,271$873,522dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock64,549$866,248dollars as filed
ADIAL PHARMACEUTICALS INC00688A304COM NEW181,890$729,379dollars as filed
ENTERA BIO LTDM40527109SHS245,098$713,235dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM41,887$708,309dollars as filed
NOVABRIDGE BIOSCIENCES44975P103CMN500,000$682,500dollars as filed
QUOIN PHARMACEUTICALS LTD74907L409SPONSORED ADS146,446$667,794dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK30,000$656,100dollars as filedput
KARDIGAN INC485925101CMN43,972$648,587dollars as filed
ENTRADA THERAPEUTICS INC COM29384C108Stock100,000$635,000dollars as filed
TANGO THERAPEUTICS INC87583X109COM25,000$623,750dollars as filed
SELLAS LIFE SCIENCES GROUP I81642T209COM NEW50,000$615,500dollars as filed
LARIMAR THERAPEUTICS INC517125100COM185,705$593,327dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS135,000$540,000dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK21,539$510,690dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK133,385$493,525dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock10,000$458,400dollars as filed
TALPHERA INC00444T209COM NEW378,037$438,523dollars as filed
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK150,000$402,000dollars as filedcall
MANNKIND CORP COM NEW56400P706Stock102,500$399,750dollars as filedcall
XENON PHARMACEUTICALS INC COM98420N105Stock10,000$371,900dollars as filed
INOVIO PHARMACEUTICALS I45773H409COMMON STOCK275,200$335,744dollars as filedcall
AETHLON MEDICAL INC00808Y703Common Stock, $0.001 par value per share50,000$326,000dollars as filed
ABEONA THERAPEUTICS INC00289Y206COM NEW51,117$268,364dollars as filed
ARDELYX INC039697107COM77,133$263,795dollars as filed
ANNEXON INC03589W102COM50,000$211,500dollars as filedcall
OCUGEN INC67577C105COMMON STOCK200,000$206,000dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock88,200$205,506dollars as filedcall
GAIN THERAPEUTICS INC36269B105COM108,200$187,186dollars as filedcall
Elicio Therapeutics Inc Com28657F103LST Equity Option100,000$182,000dollars as filedput
ATTOVIA THERAPEUTICS INC04987L102COM9,700$166,258dollars as filed
IMMATICS N.VN44445109SHS17,587$154,414dollars as filed
HERON THERAPEUTICS INC427746102COM458,723$143,810dollars as filed
AYTU BIOPHARMA INC054754858COM67,186$143,778dollars as filed
JATT II ACQUISITION CORPG50765109ORD SHS12,174$136,897dollars as filed
CELLECTAR BIOSCIENCES INC15117F880COM NEW71,382$131,343dollars as filed
ALDEYRA THERAPEUTICS INC01438T106COM88,500$108,855dollars as filedcall
PALISADE BIO INC696389402COMMON STOCK69,533$93,870dollars as filed
UNIQURE NVN90064101SHS3,400$82,144dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM5,503$72,530dollars as filed
Eli Lilly and Company532457108COM60$69,425dollars as filed
TVARDI THERAPEUTICS INC140755307COM48,491$60,614dollars as filed
COMPASS THERAPEUTICS INC20454B104COM50,000$52,000dollars as filedcall
APREA THERAPEUTICS INC03836J201COM NEW28,872$21,654dollars as filed
OUTLOOK THERAPEUTICS INC69012T305COM35,000$20,073dollars as filed
Elicio Therapeutics Inc Com28657F103LST Equity Option9,440$17,181dollars as filed
Elicio Therapeutics Inc Com28657F103LST Equity Option6,500$11,830dollars as filedcall
ROYALTY PHARMA PLCG7709Q104SHS CLASS A194$11,322dollars as filed
MAXCYTE INC57777K106COM8,190$9,173dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK500$5,500dollars as filedcall
ATYR PHARMA INC002120202COM NEW12,500$3,788dollars as filedput
JADE BIOSCIENCES INC008064206COM NEW1,046$2,930dollars as filedput
REPLIMUNE GROUP INC76029N106COMMON STOCK200$2,648dollars as filedput
INTELLIA THERAPEUTICS INC45826J105COM124$1,495dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001892688-26-000170this filing2026-11-16